We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $6.65B
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-4.72%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$4.04B
AUM Growth
-$207M
Cap. Flow
+$124M
Cap. Flow %
3.06%
Top 10 Hldgs %
5.72%
Holding
1,371
New
218
Increased
467
Reduced
361
Closed
211

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$16.1M
2
UNM icon
Unum
UNM
+$13.8M
3
DV icon
DoubleVerify
DV
+$12.9M
4
FTDR icon
Frontdoor
FTDR
+$10.5M
5
VCYT icon
Veracyte
VCYT
+$10.4M

Sector Composition

Rank Sector Weight
1 Financials 15.96%
2 Technology 15.22%
3 Industrials 15.07%
4 Healthcare 12.99%
5 Consumer Discretionary 11.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CASH icon
151
Pathward Financial
CASH
$1.87B
$7.49M 0.19%
102,647
-12,330
-11% -$941K
BMRN icon
152
BioMarin Pharmaceuticals
BMRN
$11.3B
$7.49M 0.19%
105,878
+63,783
+152% +$4.29M
FRSH icon
153
Freshworks
FRSH
$2.78B
$7.47M 0.18%
529,714
-79,896
-13% -$1.34M
ANF icon
154
Abercrombie & Fitch
ANF
$4.27B
$7.44M 0.18%
97,387
+45,849
+89% +$4.94M
APLS
155
DELISTED
Apellis Pharmaceuticals
APLS
$7.41M 0.18%
338,613
+56,328
+20% +$1.56M
GHC icon
156
Graham Holdings Company
GHC
$4.94B
$7.4M 0.18%
7,705
+4,199
+120% +$3.91M
BROS icon
157
Dutch Bros
BROS
$8.91B
$7.37M 0.18%
119,313
+31,161
+35% +$2.05M
RAMP icon
158
LiveRamp
RAMP
$2.29B
$7.36M 0.18%
281,688
-22,270
-7% -$681K
NMIH icon
159
NMI Holdings
NMIH
$3.17B
$7.36M 0.18%
204,179
+1,440
+0.7% +$52.4K
GBX icon
160
The Greenbrier Companies
GBX
$1.58B
$7.36M 0.18%
143,604
+86,900
+153% +$5.19M
AGL icon
161
Agilon Health
AGL
$2B
$7.34M 0.18%
67,799
-16,548
-20% -$1.44M
IVZ icon
162
Invesco
IVZ
$13.5B
$7.32M 0.18%
482,497
-25,660
-5% -$438K
PD icon
163
PagerDuty
PD
$680M
$7.26M 0.18%
397,212
+332,363
+513% +$6.1M
BCRX icon
164
BioCryst Pharmaceuticals
BCRX
$2.42B
$7.2M 0.18%
960,057
+234,752
+32% +$1.89M
IDA icon
165
Idacorp
IDA
$8.24B
$7.12M 0.18%
61,300
ACT icon
166
Enact Holdings
ACT
$6.39B
$7.1M 0.18%
204,311
+11,873
+6% +$397K
HRMY icon
167
Harmony Biosciences
HRMY
$2.02B
$7.1M 0.18%
213,838
-17,070
-7% -$612K
CNM icon
168
Core & Main
CNM
$8.19B
$7.09M 0.18%
146,868
FRT icon
169
Federal Realty Investment Trust
FRT
$10.8B
$7.01M 0.17%
71,669
-45,650
-39% -$4.74M
VITL icon
170
Vital Farms
VITL
$563M
$6.98M 0.17%
229,068
+121,002
+112% +$4.35M
APPF icon
171
AppFolio
APPF
$5.74B
$6.97M 0.17%
31,707
-22,502
-42% -$5.16M
LIVN icon
172
LivaNova
LIVN
$4.3B
$6.96M 0.17%
177,253
+58,540
+49% +$2.63M
CVLT icon
173
Commault Systems
CVLT
$5.81B
$6.93M 0.17%
43,923
-1,380
-3% -$227K
PRI icon
174
Primerica
PRI
$9.76B
$6.91M 0.17%
24,301
+12,190
+101% +$3.47M
AIR icon
175
AAR Corp
AIR
$5.09B
$6.9M 0.17%
123,170
+61,794
+101% +$4.11M

Similar funds

Algert Global's Q1 2025 Portfolio in Review

As of Q1 2025, Algert Global held 1,371 positions worth $4.04B, down 4.9% from $4.25B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.

Algert Global deployed $124M of net new capital in Q1 2025, opening 218 new positions and adding to 467 existing holdings. Its largest new stake was Tyson Foods: 163,910 shares worth $10.5M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Unum, an estimated $13.8M trimmed.

  • Algert Global's largest Q1 2025 buy was Tyson Foods: 163,910 shares worth $10.5M.
  • Algert Global added most to Ralph Lauren in Q1 2025, an estimated $13.4M increase.
  • Algert Global's biggest Q1 2025 reduction was Unum, cutting an estimated $13.8M.
  • Algert Global fully exited Natera in Q1 2025, selling an estimated $16.1M.
  • Algert Global's ten largest holdings make up 5.7% of its $4.04B portfolio in Q1 2025.
  • Algert Global opened 218 new positions and closed 211 in Q1 2025.
  • Algert Global's portfolio value fell 4.9% quarter-over-quarter to $4.04B.

Based on Algert Global's 13F filing for Q1 2025, filed 13 May 2025.